Please Wait.....
Report
AI in Biotechnology: Global Markets
Market Research Report I 2025-08-27 I 142 Pages I BCC Research
Description
Report Scope
The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by product type (software and services), deployment (cloud-based and on-premises), application and end user. Applications consist of drug discovery, clinical trials, diagnostics and others. End users consist of pharmaceutical and biotech companies, academic research institutes, contract R&D organizations (CROs/CDMOs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea and the Rest of Asia-Pacific.
The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies' environmental, social and corporate governance (ESG) initiatives.
Report Includes
- 50 data tables and 57 additional tables
- An analysis of the current and future global markets for artificial intelligence (AI) in biotechnology
- Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the size of the market and revenue prospects, along with a corresponding market share analysis based on product type, application, deployment type, end user, and region
- Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impact of macroeconomic variables
- Discussion of the underlying opportunities and potential, with the development of novel products, drug discovery, clinical trials and other related applications
- Insights derived from Porter's Five Forces model and global supply chain analyses
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of the leading companies, including NVIDIA Corp., Tempus AI Inc., Recursion Pharmaceuticals, Schrodinger Inc., and Sophia Genetics
Executive Summary
Summary:
The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 to 2030.
Artificial intelligence (AI) is transforming the biotech industry by enabling faster, more precise and highly scalable operations in genetic engineering, personalized medicine, agricultural biotech and drug discovery. Biotech companies are using machine learning (ML) algorithms to evaluate complex biological data, predict protein structures, discover new drug candidates and improve diagnostic accuracy, including predictive analytics for early disease identification. AI also helps in optimizing manufacturing processes and supply chains, enabling it to have an impact across the entire biotech value chain.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Overview
Potential Applications of AI in Biotechnology
Use Cases
Use Case 1: Drug Discovery
Use Case 2: Personalized Medicine
AI's Impact on the Biotech Value Chain
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of U.S. Tariffs
Porter's Five Forces Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Need for More Effective Drug Discovery and Development Process
Shift to Personalized Medicine
Growing Demand for Effective and Early Diagnosis
Rising Investments in AI in Biopharmaceuticals
Aging Population and the Growing Prevalence of Chronic Diseases
Market Restraints
Data Quality and Bias
Integration Hurdles
Ethical Concerns
Market Opportunities
AI in Synthetic Biology
Convergence of AI and Quantum Computing
Chapter 4 Regulatory Landscape
Regulatory Scenario
United States
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Emerging Trends/Technologies
Key Takeaways
Agentic AI
Generative AI
Federated Learning
Advanced Neural Networks
Chapter 6 Market Segmentation Analysis
Overview
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Software
Services
Market Analysis by Deployment Type
Key Takeaways
Cloud-based
On-premises
Market Analysis by Application
Key Takeaways
Drug Discovery
Clinical Trials and Optimization
Diagnostics
Other Applications
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Manufacturing and Development Organizations
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Mergers and Acquisitions
Agreements, Collaborations and Partnerships
Investment Landscape
Chapter 8 Sustainability in AI in Biotechnology Market: An ESG Perspective
Introduction to ESG
Sustainability Trends and Company Initiatives
ESG Risk Ratings
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
ABCELLERA BIOLOGICS INC.
ABSCI CORP.
ATOMWISE INC.
BENEVOLENTAI
DNANEXUS INC.
EUROFINS SCIENTIFIC
ILLUMINA INC.
INSILICO MEDICINE
NVIDIA CORP.
QIAGEN
RECURSION
SCHRODINGER INC.
SOPHIA GENETICS
TEMPUS AI INC.
XTALPI INC.
Other Emerging Companies in the Market
List of Tables
Summary Table : Global Market for AI in Biotechnology, by Region, Through 2030
Table 1 : Applications of AI in Biotechnology
Table 2 : Global Incidence and Mortality Cancer Rates, by WHO Region, 2022
Table 3 : Global Market for AI in Biotechnology, by Product Type, Through 2030
Table 4 : Software Platforms
Table 5 : Global Market for AI Software in Biotechnology, by Region, Through 2030
Table 6 : Global Market for AI in Biotechnology Services, by Region, Through 2030
Table 7 : Global Market for AI in Biotechnology, by Deployment, Through 2030
Table 8 : Global Market for Cloud Deployments for AI in Biotechnology, by Region, Through 2030
Table 9 : Global Market for On-Premises Deployments for AI in Biotechnology, by Region, Through 2030
Table 10 : Global Market for AI in Biotechnology, by Application, Through 2030
Table 11 : Global Market for AI in Biotechnology for Drug Discovery, by Region, Through 2030
Table 12 : Global Market for AI in Biotechnology for Clinical Trials and Optimization, by Region, Through 2030
Table 13 : Global Market for AI in Biotechnology for Diagnostics, by Region, Through 2030
Table 14 : Global Market for AI in Biotechnology for Other Applications, by Region, Through 2030
Table 15 : Global Market for AI in Biotechnology, by End User, Through 2030
Table 16 : Global Market for AI in Biotechnology for Pharma and Biotech Companies, by Region, Through 2030
Table 17 : Global Market for AI in Biotechnology for Academic Research Institutes, by Region, Through 2030
Table 18 : Global Market for AI in Biotechnology for Contract Organizations, by Region, Through 2030
Table 19 : Global Market for AI in Biotechnology for Other End Users, by Region, Through 2030
Table 20 : Global Market for AI in Biotechnology, by Region, Through 2030
Table 21 : North American Market for AI in Biotechnology, by Product Type, Through 2030
Table 22 : North American Market for AI in Biotechnology, by Deployment, Through 2030
Table 23 : North American Market for AI in Biotechnology, by Application, Through 2030
Table 24 : North American for AI in Biotechnology, by End User, Through 2030
Table 25 : North American Market for AI in Biotechnology, by Country, Through 2030
Table 26 : European Market for AI in Biotechnology, by Product Type, Through 2030
Table 27 : European Market for AI in Biotechnology, by Deployment, Through 2030
Table 28 : European Market for AI in Biotechnology, by Application, Through 2030
Table 29 : European Market for AI in Biotechnology, by End User, Through 2030
Table 30 : European Market for AI in Biotechnology, by Country, Through 2030
Table 31 : Asia-Pacific Market for AI in Biotechnology, by Product Type, Through 2030
Table 32 : Asia-Pacific Market for AI in Biotechnology, by Deployment, Through 2030
Table 33 : Asia-Pacific Market for AI in Biotechnology, by Application, Through 2030
Table 34 : Asia-Pacific Market for AI in Biotechnology, by End User, Through 2030
Table 35 : Asia-Pacific Market for AI in Biotechnology, by Country, Through 2030
Table 36 : RoW Market for AI in Biotechnology, by Product Type, Through 2030
Table 37 : RoW Market for AI in Biotechnology, by Deployment, Through 2030
Table 38 : RoW Market for AI in Biotechnology, by Application, Through 2030
Table 39 : RoW Market for AI in Biotechnology, by End User, Through 2030
Table 40 : RoW Market for AI in Biotechnology, by Sub-Region, Through 2030
Table 41 : Global Ranking of Companies in the Market for AI in Biotechnology, 2024
Table 42 : M&A in the AI in Biotechnology Industry, 2024-2025
Table 43 : Agreements and Partnerships in the Market for AI in Biotechnology, 2023-2025
Table 44 : Total Funding for AI Biotech Companies
Table 45 : ESG Risk Ratings of Companies in AI Biotechnology Market, 2024
Table 46 : Information Sources Used for this Report
Table 47 : Abbreviations Used in this Report
Table 48 : AbCellera Biologics Inc.: Company Snapshot
Table 49 : AbCellera Biologics Inc.: Financial Performance, FY 2023 and 2024
Table 50 : AbCellera Biologics Inc.: Product Portfolio
Table 51 : AbCellera Biologics Inc.: News/Key Developments, 2023-2025
Table 52 : Absci Corp.: Company Snapshot
Table 53 : Absci Corp.: Financial Performance, FY 2023 and 2024
Table 54 : Absci Corp.: Product Portfolio
Table 55 : Absci Corp.: News/Key Developments, 2023-2025
Table 56 : Atomwise Inc.: Company Snapshot
Table 57 : Atomwise Inc.: Product Portfolio
Table 58 : Atomwise Inc.: News/Key Developments, 2022
Table 59 : BenevolentAI: Company Snapshot
Table 60 : BenevolentAI: Financial Performance, FY 2022 and 2023
Table 61 : BenevolentAI: Product Portfolio
Table 62 : BenevolentAI: News/Key Developments, 2022-2024
Table 63 : DNAnexus Inc.: Company Snapshot
Table 64 : DNAnexus Inc.: Product Portfolio
Table 65 : DNAnexus Inc.: News/Key Developments, 2024-2025
Table 66 : Eurofins Scientific: Company Snapshot
Table 67 : Eurofins Scientific: Financial Performance, FY 2023 and 2024
Table 68 : Eurofins Scientific: Product Portfolio
Table 69 : Eurofins Scientific: News/Key Developments, 2024
Table 70 : Illumina Inc.: Company Snapshot
Table 71 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 72 : Illumina Inc.: Product Portfolio
Table 73 : Illumina Inc.: News/Key Developments, 2023-2025
Table 74 : Insilico Medicine: Company Snapshot
Table 75 : Insilico Medicine: Product Portfolio
Table 76 : Insilico Medicine: News/Key Developments, 2023-2025
Table 77 : Nvidia Corp.: Company Snapshot
Table 78 : Nvidia Corp.: Financial Performance, FY 2023 and 2024
Table 79 : Nvidia Corp.: Product Portfolio
Table 80 : Nvidia Corp.: News/Key Developments, 2023-2025
Table 81 : Qiagen: Company Snapshot
Table 82 : Qiagen: Financial Performance, FY 2023 and 2024
Table 83 : Qiagen: Product Portfolio
Table 84 : Qiagen: News/Key Developments, 2025
Table 85 : Recursion: Company Snapshot
Table 86 : Recursion: Financial Performance, FY 2023 and 2024
Table 87 : Recursion: Product Portfolio
Table 88 : Recursion: News/Key Developments, 2024-2025
Table 89 : Schrodinger Inc.: Company Snapshot
Table 90 : Schrodinger Inc.: Financial Performance, FY 2023 and 2024
Table 91 : Schrodinger Inc.: Product Portfolio
Table 92 : Schrodinger Inc: News/Key Developments, 2023-2024
Table 93 : Sophia Genetics: Company Snapshot
Table 94 : Sophia Genetics: Financial Performance, FY 2023 and 2024
Table 95 : Sophia Genetics: Product Portfolio
Table 96 : Sophia Genetics: News/Key Developments, 2025
Table 97 : Tempus AI Inc.: Company Snapshot
Table 98 : Tempus AI Inc.: Financial Performance, FY 2023 and 2024
Table 99 : Tempus AI Inc.: Product Portfolio
Table 100 : Tempus AI Inc.: News/Key Developments, 2023-2025
Table 101 : XtalPi Inc.: Company Snapshot
Table 102 : XtalPi Inc.: Financial Performance, FY 2023 and 2024
Table 103 : XtalPi Inc.: Product Portfolio
Table 104 : XtalPi Inc.: News/Key Developments, 2024 and 2025
Table 105 : Other Companies in the Market for AI in Biotechnology
Table 106 : Emerging Startups in the AI in Biotechnology Market
List of Figures
Summary Figure : Global Market Shares of AI in Biotechnology, by Region, 2024
Figure 1 : Potential Applications of AI in Biotechnology
Figure 2 : Impact of AI on the Biotechnology Value Chain
Figure 3 : Porter's Five Forces Analysis of the AI in Biotechnology Industry
Figure 4 : Snapshot of AI in Biotechnology Market Dynamics
Figure 5 : Emerging AI Technologies in the Biotechnology Market
Figure 6 : Global Market Shares of AI in Biotechnology, by Product Type, 2024
Figure 7 : Global Market Shares of AI in Biotechnology, by Deployment, 2024
Figure 8 : Global Market Shares of AI in Biotechnology, by Application, 2024
Figure 9 : Global Market Shares of AI in Biotechnology, by End User, 2024
Figure 10 : Global Market Shares of AI in Biotechnology, by Region, 2024
Figure 11 : North American Market Shares of AI in Biotechnology, by Country, 2024
Figure 12 : European Market Shares of AI in Biotechnology, by Country, 2024
Figure 13 : Asia-Pacific Market Shares of AI in Biotechnology, by Country, 2024
Figure 14 : RoW Market Shares of AI in Biotechnology, by Sub-Region, 2024
Figure 15 : Investments in Biopharma AI Companies, 2019-2024
Figure 16 : Market Shares of AI Biotech Startup Investment Landscape, by Funding, 2024
Figure 17 : AbCellera Biologics Inc: Revenue Share, by Business Unit, FY 2024
Figure 18 : AbCellera Biologics Inc: Revenue Share, by Country/Region, FY 2024
Figure 19 : BenevolentAI: Revenue Share, by Country/Region, FY 2024
Figure 20 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2024
Figure 21 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2024
Figure 22 : Illumina Inc.: Revenue Share, by Business Unit, FY 2024
Figure 23 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
Figure 24 : Nvidia Corp.: Revenue Share, by Business Unit, FY 2024
Figure 25 : Nvidia Corp.: Revenue Share, by Country/Region, FY 2024
Figure 26 : Qiagen: Revenue Share, by Business Unit, FY 2024
Figure 27 : Qiagen: Revenue Share, by Country/Region, FY 2024
Figure 28 : Schrodinger Inc.: Revenue Share, by Business Unit, FY 2024
Figure 29 : Schrodinger Inc: Revenue Share, by Country/Region, FY 2024
Figure 30 : Sophia Genetics: Revenue Share, by Business Unit, FY 2024
Figure 31 : Sophia Genetics: Revenue Share, by Country/Region, FY 2024
Figure 32 : Tempus AI Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33 : XtalPi Inc.: Revenue Share, by Business Unit, FY 2024
Figure 34 : XtalPi Inc.: Revenue Share, by Country/Region, FY 2024
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security